SYNTHESIS OF 2 C-14-LABELED FORMS OF PRINOMIDE, A POTENTIAL ANTIINFLAMMATORY COMPOUND AND ITS HYDROXY METABOLITE, LABELED WITH C-14

被引:0
作者
CHAUDHURI, NK
MARKUS, B
机构
[1] Preclinical Drug Metabolism Subdivision Research Department, Pharmaceuticals Division, CIBA-GEIGY Corporation, Ardsley, New York
关键词
D O I
10.1002/jlcr.2580280309
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The synthesis of two 14C‐labeled forms of prinomide, compounds 7 and 10, and the synthesis of a 14C‐labeled form of its hydroxy metabolite are described. Compound 7 was synthesized by the reaction of phenyl isocyanate and 1‐methyl‐β‐oxo‐pyrrole‐2‐propanenitrile‐carbonyl‐14C (6), which was synthesized in three steps from 1‐methylpyrrole and 14CO2. Cpmpound 10 was synthesized by the reaction of 8, the unlabeled form of the above ketonitrile, and ring‐labeled phenyl isocyanate (9), which was synthesized in three steps from benzene‐14C. The 14C‐labeled form of the hydroxy metabolite 14 was synthesized by reaction of 4‐methoxyphenyl isocyanate and the 14CN‐labeled ketonitrile 12, followed by demethylation with boron tribromide. Labeled ketonitrile 12 was synthesized from 1‐methylpyrrole, by reaction with chloroacetonitrile, followed by replacement of the chlorine atom by a 14CN group. Copyright © 1990 John Wiley & Sons, Ltd.
引用
收藏
页码:321 / 327
页数:7
相关论文
共 2 条
[1]  
EGGER H, 1988, DRUG METAB DISPOS, V16, P568
[2]  
Walker GN, 1981, Novartis Corp., Patent No. [US4256759, 4256759]